198 filings
Page 3 of 10
8-K
7kqzn87qvutfu03z 982
3 Aug 17
Bioamber Announces Record Revenues for the Second Quarter 2017 and Purchase of Mitsui Equity Stake In Sarnia Joint Venture
12:00am
8-K
hkr0p
15 May 17
BioAmber Announces Changes to its Board of Directors, the Appointment of a
12:00am
8-K
oydkdcms62dg
9 May 17
BioAmber Reports First Quarter 2017 Financial Results
12:00am
25-NSE
p0t5jpcreowtu8a
5 May 17
Exchange delisting
12:00am
8-K
nmj6l0
4 May 17
Other Events
12:00am
CT ORDER
5i1gnoh3r7xsz8e1
4 Apr 17
Confidential treatment order
12:00am
DEFA14A
g37yl3f1
31 Mar 17
Additional proxy soliciting materials
12:00am
8-K
ic688x kl7j83e
31 Mar 17
BioAmber Announces CFO Transition
12:00am
8-K
qt9lzwhcyyhz bjo5
16 Mar 17
BioAmber Announces Year End Operational and Financial Results for 2016
12:00am
8-K
qsrjxm1d5ohz
21 Feb 17
Entry into a Material Definitive Agreement
12:00am
8-K
a0j0 whe3s4gu8xxu
30 Jan 17
Termination of a Material Definitive Agreement
12:00am
8-K
jlqogh yk
27 Jan 17
Bioamber Inc. Increases Previously Announced Public Offering to US$17.5 Million
12:00am
FWP
xsvke12ax4 4t0
24 Jan 17
Free writing prospectus
12:00am
424B5
e89lxdnl9n eaqz9umi
24 Jan 17
Prospectus supplement for primary offering
12:00am
FWP
8he07t05 d7fnu
23 Jan 17
Free writing prospectus
12:00am
8-K
9nimqik34h0i s8bxm
23 Jan 17
Bioamber Inc. Announces US$10 Million Underwritten Public Offering
12:00am
424B5
yelpm46favlu
23 Jan 17
Prospectus supplement for primary offering
12:00am